Codexis

Codexis develops enzyme-based biocatalysis solutions for pharmaceutical manufacturing and RNA therapeutics production. The company uses its proprietary CodeEvolver® technology platform to engineer custom enzymes that enable more efficient and sustainable synthesis processes for active pharmaceutical ingredients and therapeutic molecules. UpGuard continuously monitors the security posture of Codexis using open-source, commercial, and proprietary threat intelligence feeds. Our analysis is centered on objective, externally verifiable information.

Codexis Security Rating

X
---
/ 950
Codexis's security rating is based on the analysis of their external attack surface. The higher the rating, the better their security posture. Start a free trial to get a more in-depth risk assessment for Codexis.

Company info

Codexis
Company
Codexis
Employees
Location
CEO
John J. Nicols
Last updated
Last updated
Industries
Last updated today

Codexis Vendor Risk Report

This vendor risk report is based on UpGuard’s continuous monitoring of Codexis's security posture using open-source, commercial, and proprietary threat intelligence feeds. The results are summarized into a security rating based on the analysis of hundreds of individual checks across five risk categories: website security, email security, phishing & malware, brand & reputation risk, and network security.

Last updated today

Codexis Data Breaches, Cybersecurity Incidents and News

Security incidents, news, and data leaks relating to Codexis.

Security reports related to Codexis

Compare Codexis's security performance with other companies in their industry.
Free instant security score

How secure is your organization?

Request a free cybersecurity report to discover key risks on your website, email, network, and brand.
  • Check icon
    Instant insights you can act on immediately
  • Check icon
    Hundreds of risk factors including email security, SSL, DNS health, open ports and common vulnerabilities
Website Security scan resultsWebsite Security scan rating